Ocular use of gentamicin and cephaloridine. II. In vitro and patient studies.
D001082:Aqueous Humor / Q000382:microbiology; D001407:Bacillus / Q000302:isolation & purification; D002509:Cephaloridine / Q000008:administration & dosage / Q000494:pharmacology*; D003228:Conjunctiva / Q000382:microbiology; D016039:Corneal Transplantation; D003320:Corneal Ulcer / Q000188:drug therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D004754:Enterobacter / Q000302:isolation & purification; D005128:Eye Diseases / Q000188:drug therapy; D005131:Eye Injuries / Q000188:drug therapy; D005839:Gentamicins / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011549:Pseudomonas / Q000187:drug effects* / Q000302:isolation & purification; D013210:Staphylococcus / Q000302:isolation & purification; D014184:Transplantation, Homologous; D014605:Uveitis / Q000188:drug therapy*
D004338:Drug Combinations; D005839:Gentamicins; D002509:Cephaloridine